Stock listing
NASDAQ:ADVM Adverum Biotechnologies Inc Stock
Follow Adverum Biotechnologies Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ADVM
$4.36 USD
Close on Dec 9, 2025 · No longer trades
- Lowest – highest close
- $2.05 – $16.06 USDSince Mar 21, 2024 · lowest May 15, 2025 · highest Mar 22, 2024
Delisted NASDAQ:ADVM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ADVM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest deck · Dec 4, 2025
FLORetina December 2025
Conference · 19 slides
Adverum Biotechnologies Inc on 6ix
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 1, 2021
- Decks
- 11 decks · latest Dec 4, 2025
Events
| Call | When | Status |
|---|---|---|
| Adverum Biotechnologies (ADVM) Q4 2020 Earnings Call | Mon, Mar 01, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FLORetina December 2025 | Conference | 19 slides | Dec 4, 2025 |
| Technical Presentation (November 2024) | Technical | 78 slides | Nov 18, 2024 |
| Corporate Update (July 2024) | Corporate update | 39 slides | Jul 17, 2024 |
| Technical Presentation (February 2024) | Technical | 32 slides | Feb 8, 2024 |
| Proxy Contest (April 2021) | Proxy contest | 10 slides | Apr 26, 2021 |
| Proxy Contest (April 2021) | Proxy contest | 65 slides | Apr 22, 2021 |
| Q4 2020 Earnings Presentation | Earnings | 22 slides | Mar 1, 2021 |
| Investor Presentation (October 2016) | Investor deck | 15 slides | Oct 13, 2016 |
| Avalanche Biotechnologies — Merger or Acquisition (March 2016) | Merger or acquisition | 36 slides | Mar 10, 2016 |
| Avalanche Biotechnologies — Merger or Acquisition (February 2016) | Merger or acquisition | 34 slides | Feb 22, 2016 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Avalanche Biotechnologies — Merger or Acquisition (February 2016) | Merger or acquisition | 42 slides | Feb 17, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · Since at least Mar 14, 2017 |
| Dawn Svoronos Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Global Blood Therapeutics Inc (Director · Dec 19, 2018 – Oct 5, 2022 · Past); Endocyte Inc (Director · May 3, 2018 – Dec 21, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past); Medivation Inc (Director · Apr 22, 2013 – Sep 28, 2016 · Past) | Director · Since at least Dec 9, 2020 |
| Linda Bain Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); VBI Vaccines Inc. (Director · Jul 1, 2021 – Jan 27, 2022 · Past); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Bluebird bio Inc (VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past) | Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past |
| Mitchell H Finer Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 13, 2019 · Past); Bluebird bio Inc (Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past) | Director · May 11, 2016 – Jul 31, 2019 · Past |
| Amber Salzman Other companies: Akcea Therapeutics Inc (Director · Feb 12, 2020 – Oct 12, 2020 · Past) | President and CEO, Director · May 11, 2016 – Feb 15, 2018 · Past |
| C. David Nicholson Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Director · Since at least Dec 28, 2023) | Director · Since at least Nov 3, 2023 |
| Hans Hull Other companies: Pliant Therapeutics, Inc. (Chief Business Officer · Jun 2, 2020 – Jan 23, 2025 · Past) | Chief Executive Officer · Jul 30, 2014 – Aug 21, 2015 · Past |
| Reed V. Tuckson Other companies: Henry Schein, Inc. (Director · Since at least Mar 1, 2024) | Director · Since at least Jun 17, 2024 |
| Samuel B Barone Other companies: Disc Medicine, Inc. (Chief Medical Officer · Apr 12, 2021 – Apr 12, 2021 · Past) | SVP, Clinical Development · Jul 30, 2014 – Feb 9, 2017 · Past |
| Brigit Riley | Chief Scientific Officer · Sep 2, 2021 – Mar 15, 2023 · Past |
All 21 people
| Person | Seat |
|---|---|
| Jack Anthony Thrift | Interim CFO · Sep 2, 2021 – Sep 2, 2021 · Past |
| Julie Clark | Chief Medical Officer · Jun 1, 2021 – Sep 30, 2021 · Past |
| Mark L Lupher Jr | Director · Since at least May 1, 2019 |
| Nancy E Pecota | Principal Accounting Officer · Jun 6, 2022 – Jun 6, 2022 · Past |
| Peter Soparkar | CHIEF OPERATING OFFICER · Since at least Feb 16, 2021 |
| Rupert D'Souza | Chief Financial Officer · Dec 6, 2021 – May 13, 2022 · Past |
| Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER · Since at least Jan 6, 2022 |
| Soo Hong | Director · Since at least Jun 17, 2025 |
| Steven Daniel Schwartz | Director · Jul 30, 2014 – Jun 12, 2017 · Past |
| Szilard Kiss | Director · Since at least Jun 10, 2024 |
| Thomas W Chalberg | Chief Executive Officer, Director · Jul 30, 2014 – Jun 10, 2015 · Past |
Log in to ask 6ix AI your own questions about Adverum Biotechnologies Inc.